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ABSTRACT
Post-transcriptional RNA modifications, the epitran-
scriptome, play important roles in modulating the
functions of RNA species. Modifications of rRNA are
key for ribosome production and function. Identifica-
tion and characterization of enzymes involved in epi-
transcriptome shaping is instrumental for the eluci-
dation of the functional roles of specific RNA modifi-
cations. Ten modified sites have been thus far identi-
fied in the mammalian mitochondrial rRNA. Enzymes
responsible for two of these modifications have
not been characterized. Here, we identify METTL15,
show that it is the main N4-methylcytidine (m4C)
methyltransferase in human cells and demonstrate
that it is responsible for the methylation of position
C839 in mitochondrial 12S rRNA. We show that the
lack of METTL15 results in a reduction of the mito-
chondrial de novo protein synthesis and decreased
steady-state levels of protein components of the ox-
idative phosphorylation system. Without functional
METTL15, the assembly of the mitochondrial ribo-
some is decreased, with the late assembly compo-
nents being unable to be incorporated efficiently into
the small subunit. We speculate that m4C839 is in-
volved in the stabilization of 12S rRNA folding, there-
fore facilitating the assembly of the mitochondrial
small ribosomal subunits. Taken together our data
show that METTL15 is a novel protein necessary for
efficient translation in human mitochondria.
INTRODUCTION
Mammalian mitochondrial DNA (mtDNA) encodes 13
polypeptides that are essential subunits of the oxidative
phosphorylation (OxPhos) system. MtDNA also contains
the genes for all 22 mitochondrial (mt-) tRNAs and twomt-
rRNAs (small 12S and large 16S). The maintenance and ex-
pression of the mitochondrial genome is entirely dependent
on proteins encoded in the nucleus, which upon transla-
tion on cytoplasmic ribosomes are imported intomitochon-
dria. Expression of mitochondrial genes shows very distinct
differences as compared to their nuclear-encoded counter-
parts, particularly with respect to protein synthesis. Mam-
malian mitoribosomes differ considerably from other ribo-
somes as far as architecture and composition is concerned,
with the key differences being the reversed protein:RNA
mass ratio and many novel, mitochondria-specific protein
components. Mammalian mitoribosomes are composed of
the mtDNA-encoded 12S and 16S rRNA and 82 nucleus-
encoded mitoribosomal proteins (MRPs) (1–3). The 5S
rRNA conventionally present as a third rRNA component
in bacterial and cytoplasmic ribosomes has been replaced
by mt-tRNAVal (e.g. human, rat) or mt-tRNAPhe (e.g. pig,
cow) in the central protuberance of the mitochondrial large
ribosomal subunit (mt-LSU) (1,4–6). Although the struc-
ture of the mammalian mitoribosome has been determined,
little is known about the assembly mechanism. Given the
divergence of the mammalian mitoribosome from its ances-
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tor, its assembly pathway is likely to be considerably differ-
ent from its bacterial counterpart, implying the presence of
mitochondria-specific regulatory factors. Recently, a series
of pulse-labelled SILAC experiments has given the first im-
portant insight into the kinetic appearance of newly synthe-
sized MRPs in the assembled mitoribosome (7), although
the exact mechanism is still to be unravelled.
In all kingdoms of life, rRNAs undergo multiple post-
transcriptional modifications, which are crucial for ribo-
some biogenesis and/or efficient translation. In compar-
ison with bacterial and eukaryotic cytoplasmic rRNAs,
the number of modifications observed in mitochondrial
rRNAs is low. Only ten modified sites have been iden-
tified in 12S and 16S mt-rRNA thus far, whereas >200
and >30 modified nucleotides have been detected in eu-
karyotic cytoplasmic and bacterial ribosomes, respectively.
Mammalian large 16S rRNAhas three 2′-O-ribosemethyla-
tions, Gm1145, Um1369 andGm1370 (m. 2815G,m.3039T,
m.3040G, respectively, human mtDNA numbering), catal-
ysed by MRM1, MRM2 and MRM3, respectively (8–10)
and a base methylation at position m1A947 (m.2617A),
catalysed by TRMT61B (11). Furthermore, mammalian
16S rRNA contains one pseudouridine () at position 1397
(m.3067T) (12), which is predicted to be introduced by
RPUSD4 (13,14). Five base methylations have been iden-
tified in the small 12S rRNA (15). Positions m62A936 and
m62A937 (m.1592A and m.1593A) of the mammalian 12S
rRNA are methylated by TFB1M (16,17), while the C5
methylation of C841, m5C841 (m.1488C), is catalysed by
NSUN4 (18). The enzymes responsible for the remain-
ing two methylations detected in mammalian 12S rRNA,
m5U429 (m.1076T) and m4C839 (m.1486C) are still await-
ing identification.
Methylation of the small subunit (SSU) rRNA posi-
tion equivalent to the 12S mt-rRNA m4C839 is strongly
conserved in bacteria (m4C1402 in the SSU 16S rRNA
in Escherichia coli) (19–22). The enzyme responsible
for m4C1402 in E. coli has been identified as RsmH
(also known as mraW) and is an S-adenosyl methion-
ine (SAM)-dependent methyltransferase. RsmH shows se-
quence homology with mammalian methyltransferase-like
family (METTL) members. Proteins of this family are in-
volved in multiple cellular functions. For example, the
METTL3/METTL14 complex and METTL16 methylate
N6-adenosine on mammalian nuclear-encoded RNA (23),
METTL1 methylates N7-guanosine of yeast and human
tRNA (24–26), and METTL12 is a mitochondrial methyl-
transferase that modifies citrate synthase (27).
We have recently shown that defects in the nucleotide
modification of mt-rRNA can lead to a human disorder of
mitochondrial respiration (28). Here we demonstrate that a
previously uncharacterized protein, encoded in the nucleus
by METTL15, is localized in mitochondria in human cells
and is required for the introduction of N4-methylcytidine at
position 839 of human 12Smt-rRNA.Our study also shows
thatMETTL15 is necessary for efficient mitochondrial pro-
tein synthesis and mitoribosome biogenesis. These findings
on the role of METTL15 provide new insights into the mi-
toribosome assembly process and, in the long-term, can
help pave theway for the development of futuremechanism-
based therapies for mitochondrial diseases.
MATERIALS AND METHODS
Maintenance and transfection of mammalian cell lines
HeLa cells, used for immunofluorescence and siRNAmedi-
ated knockdown of METTL15 were grown at 37◦C in a hu-
midified atmosphere with 5% CO2 in high-glucose DMEM
supplemented with 10% foetal bovine serum.
The Flp-In T-Rex HEK293T cell line was used
to generate a doxycycline-inducible expression of
METTL15.FLAG.STREP2. The full-length METTL15
cDNA construct (IMAGE clone: 4657323 with sequence
corrected using site-directedmutagenesis) was cloned into a
pcDNA5/FRT/TO plasmid encoding FLAG.STREP2-tag
as previously described (29). The oligonucleotides used for
cloning can be found in Supplementary Table S1. Cells were
grown in the same medium described above, supplemented
with selective antibiotics hygromycin (100 g/ml) and
blasticidin (15 g/ml). Wild type andMETTL15 knockout
HAP1 cells were grown in Iscove’s Modified Dulbecco’s
Medium (IMDM) supplemented with 10% fetal bovine
serum or IMDM medium for SILAC supplemented with
Arg, Lys and Pro and 10% dialysed FCS (Thermo Scien-
tific HyClone). METTL15 was knocked-out in HAP1 cells
using CRISPR/Cas9 by Horizon Discovery.
Cell fractionation
Fractionation experiments were performed by differential
centrifugation as previously described (29), omitting the su-
crose gradient step. Briefly, following trypsinisation, cells
were washed with PBS and resuspended in hypotonic buffer
containing 20 mM HEPES (pH 7.8), 5 mM KCl, 1.5 mM
MgCl2 with 1 mg/ml BSA and protease inhibitors (Roche),
incubated on ice for 10 min and homogenized with a Balch
homogeniser with a 10 m clearance ball bearing. Next,
two-thirds of total homogenate volume of 2.5×MSHbuffer
(525 mM mannitol, 175 mM sucrose, 20 mM HEPES (pH
7.8), 5 mM EDTA and protease inhibitor cocktail) was im-
mediately added. 1× MSH buffer was added up to 30 ml.
Next differential centrifugation was used to obtain the dif-
ferent cell fractions (1000 × g for 10 min to remove cell de-
bris and nuclei, next for 10 min at 10 000 × g to pellet the
mitochondria).
Immunodetection of proteins
The immunofluorescence analysis was performed essen-
tially as described previously (30). Briefly, HeLa cells
were grown on coverslips and transiently transfected
withMETTL15.FLAG.STREP2 using Lipofectamine 2000
(Thermofisher) for 24 h and fixed with 4% formaldehyde so-
lution. After permeabilization with 1% Triton X-100, cells
were incubated with the following antibodies: rabbit anti-
FLAG (Sigma-Aldrich, F3165, 1:200), mouse anti-TOM20
(Santa Cruz Biotechnology, sc-11415, 1:500) followed by
Alexafluor-488 anti-mouse or Alexafluor-594 anti-rabbit
(Molecular Probes). Mounting medium used was ProLong
Gold Antifade Mountant with DAPI (Molecular Probes).
For western blot analysis, 20–30 g of extracted pro-
teins were loaded on SDS-PAGE 4–12% bis–tris gels (Life
Technologies) and transferred onto a membrane using
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iBlot 2 Dry Blotting System (Thermo Fisher Scientific).
The following antibodies were used: rabbit anti-METTL15
(Sigma-Aldrich, HPA048994, 1:1000), mouse anti-TOM22
(Abcam, ab10436, 1:2000), mouse anti-GAPDH (Ab-
cam, ab9484, 1:5000) mouse anti-FLAG (Sigma, F3165,
1:1000), Total OXPHOS Human WB antibody cocktail
(Abcam, ab110411, 1:1000), mouse anti-Beta actin (Sigma-
Aldrich, A1978, 1:75 000), mouse anti-mtSSB1 (a kind
gift of Prof. D. Kang, 1/4000), rabbit anti-uL3m (Sigma-
Aldrich, HPA043665, 1:2000), rabbit anti-bL112m (Pro-
teintech, 14795-1-AP, 1:2000), rabbit anti-uS17m (Protein-
tech, 18881-1-AP, 1:1500), rabbit anti-mS40 (Proteintech,
16139-1-AP, 1:1500), mouse anti-mS29 (Abcam, ab11928,
1:1000), rabbit anti-uL223m (Proteintech, 11706-1-AP,
1:1000), mouse anti-SDHB (Life Technologies, 459230,
1:500).
Gene silencing by RNAi
Stealth siRNAs were obtained from Thermo Fisher Scien-
tific and transfected into HeLa cells using Lipofectamine
RNAiMAXReagent (ThermoFisher Scientific). Sequences
can be found in Supplementary Table S1.
Mitochondrial DNA copy number analysis
Total cellular DNA was isolated from HAP1 cells using
a DNeasy Blood and Tissue kit (Qiagen) according to
the manufacturer’s recommendations. Copy numbers of
mtDNA were measured by quantitative PCR as described
previously (31). Primer and probe sequences can be found
in Supplementary Table S1.
RNA extraction and RT-qPCR
Measurements ofRNA steady-state levels byRT-qPCRwas
performed as described previously (32). Briefly, RNA was
extracted with TRIzol reagent (Thermo Fisher Scientific)
and treated with TURBO DNase (Ambion) according to
manufacturer’s instructions. 1 g RNA was reverse tran-
scribed using Omniscript RT kit (Qiagen) with 0.5 M ran-
dom hexamers and 0.5 M oligo dT primers. RT-qPCR
primer and probe sequences can be found in Supplemen-
tary Table S1.
35S-methionine metabolic labelling of mitochondrial proteins
To label newly synthesised mtDNA-encoded proteins
the previously published protocol was used (33).
Briefly, exponentially growing cells were incubated in
methionine/cysteine-free medium for 10 min before the
medium was replaced with methionine/cysteine-free
medium containing 10% dialysed FCS and emetine dihy-
drochloride (100 g/ml) to inhibit cytosolic translation.
Following a 20 min incubation, 120 Ci/ml of [35S]-
methionine (Perkin Elmer) was added and the cells were
incubated for 30 min. For the pulse-chase experiments,
the labelling medium was removed and cells were allowed
to grow for 7 and 14 h in normal growth medium before
collection. After washing with PBS, cells were lysed and
30 g of protein was loaded on 10–20% Tris-glycine
SDS-PAGE gels. Products were visualized and quantified
with a PhosphorImager system with ImageQuant software.
RNA mass spectrometry
Mitochondrially-enriched RNA was digested to compo-
nent nucleosides with an enzyme cocktail of benzonase,
phosphodiesterase and alkaline phosphatase (Merck), all
used as according to the manufacturer’s instructions. Nu-
cleosides were separated by reverse phase liquid chromatog-
raphy - eluent A was 0.1% (v/v) formic acid in water, and
eluent B was 0.1% (v/v) formic acid in acetonitrile, and a
non-linear gradient of 2–15% B resolved nucleosides across
a Waters Acquity HSS T3 C18 column. The eluent was
sprayed into a Sciex 4500 triple quadrupole mass spec-
trometer and characterized by tandem mass spectrome-
try using a multiple reaction monitoring approach. Injec-
tion amounts were normalized by internal calibration with
isotopically-labelled uridine and quantification performed
using external calibration of a range of nucleoside stan-
dards.
Targeted RNA bisulfite sequencing
Bisulfite conversion of 2 g DNase treated RNA was per-
formed using the Imprint DNA Modification kit (Sigma).
The reaction mixture was incubated for three cycles of 90◦C
for 5 min and 60◦C for 1 h. Following desalting with Micro
Bio-spin 6 chromatography columns (Bio-Rad) twice, RNA
was desulfonated by adding an equal volume of 1 M Tris
(pH 9.0) and incubated for 1 h at 37◦C. After ethanol pre-
cipitation, reverse transcriptionwas performedwith specific
primers (Superscript II, Life technologies). After the first
stage PCR with overhang primers (Supplementary Table
S1), excess primers were removed with Ampure XP beads.
An 8 cycles second round PCR was performed with in-
dexed primers (Nextera XT), followed by another clean-up
with Ampure XP beads. Quality and concentration were as-
sessed with a D1000 Screentape for TapeStation (Agilent
Genomics). Libraries were subjected to high-throughput se-
quencing using the Illumina MiSeq platform. After quality
trimming and 3′ end adaptor clipping with Trim Galore!,
reads longer than 20 nt were aligned to a computation-
ally bisulfite-converted human reference genome (GRCh38)
with Bismark (34).
Complementation ofMETTL15KO lines withWTormutant
METTL15 cDNA
The METTL15 WT cDNA described above was subjected
to site-directed mutagenesis to encode predicted catalyt-
ically inactive protein. Primer sequences can be found
in Supplementary Table S1. PCR products were cloned
into the lentiviral vector pWPXLd-ires-PuroR (derived
from pWPXLd, Addgene #12258). Human 293T cells
were plated at 2.5–3 × 106 cells per 10 cm plate, 24 h
before cotransfection with 10 g of METTL15 cDNA-
containing transfer vector, 6.55 ug of second-generation
packaging plasmid (psPAX2) and 3.5 g of envelope plas-
mid (pMD2.G) using FuGENE 6 Transfection Reagent
(Roche). Viral particles were collected 24 h after trans-
fection. METTL15 KO HAP1 cells were transduced with
lentiviral particles carrying the WT METTL15 gene or a
putative catalytically inactive mutant. Cells were selected
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with puromycin (0.5 g/ml) for 14 days and bulk popula-
tions of cells were subjected to further analysis.
Protein co-immunopurification
Mitochondria were isolated by differential centrifugation
from HEK293T cells expressing a tagged METTL15 pro-
tein. Pelleted mitochondria were resuspended in lysis buffer
and immune affinity purificationwas performedwith anM2
affinity gel kit with elution of the native protein conducted
with peptide following the manufacturer’s protocol (Sigma-
Aldrich).
Analysis of the mitochondrial ribosome profile on sucrose
density gradients
Wild type or METTL15 KO HAP1 cells were grown in
‘heavy’, containing 15N and 13C-labelled Arg and Lys, or
‘light’ labelled media. Both cell lines were pooled together
and mitochondrial isolation was performed as described
above, before lysis and loading on a linear sucrose gradient
(10–30%) in 50 mM Tris–HCl (pH 7.2), 10 mMMg(OAc)2,
40 mM NH4Cl, 25 mM KCl and centrifuged for 2 h 15
min at 100 000 × g max at 4◦C. Fractions (of 100 l
each) were collected, and 30 L portions were precipitated
with 20× volume of ethanol overnight and precipitants di-
gested with 1:100 (w/w) of trypsin in 50 mM NH4HCO3
overnight. Liquid chromatography-tandemmass spectrom-
etry (LC–MS/MS) analysis of the peptides was carried out
using a Thermo Scientific Orbitrap LTQ XL mass spec-
trometer and a Proxeon EasyLC nanoscale chromatograph.
Spectral data was analysed by Thermo Proteome Discov-
erer software which directed firstly protein identification
with Matrix Science Mascot software (configured to query
the human Uniprot database) and then performed relative
quantification of peptide precursors. Custom Python andR
scripts were written and used to separate results for heavy
and light-isotope-labelled peptides into control and treat-
ment batches, and from them to identify peptides to rep-
resent relative protein abundance and create relative abun-
dance profiles across the sucrose gradient.
Structural modelling of human METTL15
Amino acid sequence for METTL15 was retrieved from
Uniprot (A6NJ78) (Supplementary Figure S2: Transcript
ID ENST00000407364.7) and modelled using E. coli high
resolution crystal structures for methyltransferase Rsmh
(PDB:3TKA) as template using the Swiss-Model homol-
ogy modelling server. AdoMet from the bacterial structure
and the residues involved in the AdoMet-binding in the E.
colimethyltransferase were identified and mapped onto the
aligned structures to analyse conservation of catalytically
important residues. Structure visualization and mapping of
residues was performed using PyMOL (35).
Evaluation of structural proximity
The structure of the human mitoribosome (PDB 3J9M
(1,4)) was inspected for the closest ribosomal proteins to
12S C839. First, the central position of residue C839 was
determined using all of its atoms (20 atoms), and the re-
sulting coordinate was used to calculate the distance to all
atoms from the protein components of the mitoribosomal
small subunit. Individual distances between atoms were de-
termined by inspection of the structure using PyMOL (35).
RESULTS
METTL15 is localized in human mitochondria
To examine if METTL15 is a mitochondrial protein, we
transiently expressed a FLAG-tagged version of the pro-
tein in HeLa cells and subjected these cells to immunofluo-
rescence detection. In this analysis, METTL15 co-localized
with the mitochondrial protein TOM20 in HeLa cells (Fig-
ure 1A). Subsequent cellular fractionation experiments of
HEK293T cells stably expressing the FLAG-tagged ver-
sion of METTL15 indicated that METTL15 is enriched
within the mitochondrial fraction, along with mtSSB1, a
well-characterized mitochondrial matrix protein (Figure
1B). Both mtSSB1 and METTL15 were resistant to pro-
teinase K treatment of the mitochondrial fraction, whereas
the outer membrane protein TOM22 was truncated by
proteinase K digestion in similar conditions. Although
METTL15 has no predicted mitochondrial targeting se-
quence, our results clearly indicate that METTL15 is an
intra-mitochondrial protein in human cells. Our results are
consistent with a large-scale proteomic study based on prox-
imity labelling that suggested mitochondrial matrix local-
ization of METTL15 (36), as well as with a recent BioID
study suggesting that METTL15 interacts with TRUB2, a
mitochondrial matrix pseudouridine synthase (13).
Mitochondrial translation is impaired inMETTL15 deficient
cells
To study the function of METTL15, the coding gene
was knocked-out using CRISPR/Cas9 in HAP1 cells. The
METTL15 gene has twelve transcripts, of which six are
protein coding (Supplementary Figure S1A). The knock-
out (KO) cell line carried a 14 bp deletion in exon 3, com-
mon to all protein coding transcript isoforms (Supplemen-
tary Figure S1A–C). NoMETTL15 protein was detected in
the knockout cells in western blot analysis, consistent with
a complete ablation of gene expression (Figure 2A).
To characterize the mitochondrial role of METTL15, we
first assessed mitochondrial gene maintenance and expres-
sion in the absence of METTL15. We did not detect any
appreciable changes in mtDNA copy number inMETTL15
KO as compared to wild-type (WT) HAP1 control cells
(Supplementary Figure S2A), consistent with mitochon-
drial biogenesis and maintenance of the mitochondrial
genome being unaffected in the absence of METTL15. To
test whether the lack of METTL15 affects mt-RNA expres-
sion we used qPCR to measure mt-RNA steady-state lev-
els. No statistically significant difference in mitochondrial
transcript levels was observed in cells lacking METTL15
(Supplementary Figure S2B). Since RT-qPCR detects ma-
ture transcripts as well as precursor mt-RNA, we also as-
sessed mature mt-RNA specifically by northern blot analy-
sis. No significant differences in mature mt-RNA were ob-
served (Supplementary Figure S2C).
Nucleic Acids Research, 2019, Vol. 47, No. 19 10271
Figure 1. METTL15 localizes in the mitochondrial matrix. (A) Immunofluorescence labelling of a Flag-tagged METTL15 construct (red) in HeLa cells.
Cells were counterstained for the mitochondrial import receptor subunit TOM20 (green) and DAPI (blue). Scale bar, 10 m. (B) Sub-cellular localisation
of METTL15 analysed by western blotting with antibodies against METTL15, Flag, TOM22 (mitochondrial outer membrane), mtSSB1 (mitochondrial
matrix) and GAPDH (cytosol). HEK293T cells expressing a Flag-tagged METTL15 construct were fractionated into debris (D, lane 2), cytosol (C, lane3)
and mitochondria (M, lane 4–6). ‘T’ indicates the total cell lysate. ‘fl’ indicates full-length TOM22, ‘tr’ stands for truncated TOM22.
We next asked whether the lack of the METTL15 pro-
tein affectsmitochondrial translation.Wemeasured the rate
of mitochondrial protein synthesis by metabolic labelling
with radioactively labelled methionine upon inhibition of
cytosolic translation. This analysis revealed that the mito-
chondrial de novo protein synthesis rate was generally de-
creased in the absence of METTL15 (Figure 2B and C).
We also performed pulse-chase labelling of mitochondrial
de novo protein synthesis and observed comparable stabil-
ity of mtDNA-encoded 7 and 14 h after labelling inWT and
METTL15KOcells. This result suggests that inactivation of
METTL15 does not affect translation fidelity and/or mem-
brane insertion of the mtDNA-encoded proteins (Supple-
mentary Figure S3). To confirm this result in a different
human model, we silenced METTL15 in HeLa cells using
RNA interference (Supplementary Figure S4). Cells treated
with siRNA against METTL15 also showed a lower mito-
chondrial translation rate (Supplementary Figure S4A-B).
Furthermore, we asked whether the observed deficiency in
mitochondrial translation resulted in reduced levels of res-
piratory complexes containing mtDNA-encoded subunits.
Western blot analysis indicated that the steady-state levels
of the protein component of complex I, III and IV were sig-
nificantly reduced in METTL15 KO cells (Figure 3D and
E) and in cells treated withMETTL15 siRNA (Supplemen-
tary Figure S4C andD). Taken together, our data show that
METTL15 is necessary for efficient mitochondrial protein
synthesis.
METTL15 is an m4C methyltransferase
The N4-methylcytidine at C1402 (m4C1402) modification
in the decoding centre of SSU is strongly conserved in bacte-
rial species, includingE. coli andThermotoga maritima (19–
22). Although, m4C1402 is regarded as a bacteria-specific
modification, recently Leishmania, have also been shown to
contain an equivalent SSU rRNA modification (m4C2059)
(37). HumanMETTL15 shows sequence homology to bac-
terial RsmH which introduces m4C1402 in the SSU 16S
rRNA in E. coli (Supplementary Figure S5). C1402 is lo-
cated in helix 44 (h44) ofE. coli 16S rRNA and is equivalent
to C839 in human 12S mt-rRNA (Supplementary Figure
S6); the position that has been previously reported to con-
tain a conserved N4-methylcytidine in mammals (18,38).
The E. coli, RsmH monomer consists of two structurally
related domains: the methyltransferase domain and the cy-
tidine binding-like domain (39). Homology modelling indi-
cated that human METTL15 is also structurally related to
RsmH (Figure 3A). The key residues of the active site are
conserved between humanMETTL15 and RsmH, suggest-
ing that the human protein is also an active methyltrans-
ferase (Figure 3B-C and Supplementary Figure S5). Given
the sequence and structure homology between METLL15
andRsmH, we speculated thatMETTL15 is responsible for
methylation of m4C839 in human 12S mt-rRNA. To test
this, we examined whether ablation of METTL15 results in
changes in m4C levels using mass spectrometry (RNAMS).
Application of standards showed that in the conditions used
RNA MS is able to discriminate between m3C, m4C and
m5C (Supplementary Figure S7A). We quantified several
modified nucleosides in total RNA preparations from WT
HAP1 cells, however, we were not able to detect any signal
for m4C (Supplementary Figure S7B). Next, we analysed
the same set of nucleosides in mitochondria-enriched RNA
preparations fromWT andMETTL15 KOHAP1 cells. En-
riching samples with mtRNA allowed for measuring low
levels of m4C in WT HAP1 cells (Figure 3D, E and Supple-
mentary Figure S7C, grey bars).While most modified RNA
nucleosides showed comparable levels in mtRNA-enriched
preparations from WT and METTL15 KO cells, m4C was
present at undetectable levels in the METTL15 KO cells
(Figure 3D, E and Supplementary Figure S7C). These re-
sults indicate that METTL15 is a homologue of bacterial
RsmH and it is a mitochondrial m4C methyltransferase.
This analysis also shows that mtRNA is the major source
of cellular m4C, indicating that METTL15 is the main m4C
methyltransferase in human cells.
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Figure 2. METTL15 is essential for mitochondrial translation. (A) Western blot analysis of METTL15 in wild type (WT) and METTL15 KO HAP1 cells.
(B) Mitochondrial de novo protein synthesis was assessed with 35S metabolic labelling. Coomassie blue stained (CBS) gel was used as loading control.
(C) Quantification of the band intensities shown in B using ImageJ. (D) Representative example of western blot analysis of NDUFB8, SDHB, UQCRC2,
COXII, ATP5A and Beta actin. (E) Quantification of 4 western blot experiments for NDUFB8, SDHB, UQCRC2, COXII, ATP5A. Data were statistically
analysed by two-tailed Student’s t-test. Error bars represent standard deviation of the mean.
METTL15 methylates 12S mt-rRNA at position C839
Thus far, m4C839 in 12S mt-rRNA is the only N4-
methycytidine reported in mammalian mitochondria
(38,40). In order to investigate if the lack of m4C signal
in METTL15 KO cells in the RNA MS experiments
corresponds to the reduction of m4C839 on 12S mt-rRNA
we performed targeted RNA bisulfite sequencing (BS
RNA-Seq), which combines bisulfite treatment of RNA
with high-throughput sequencing. Bisulfite deamination is
widely used to study m5C (32,41), however, this technique
can also be employed to detect m4C, although conversion
efficacy for m4C is lower as compared to m5C (42). The BS
RNA-Seq analysis confirmed the existence of a modified
base at C839 in human 12S mt-rRNA in wild type human
HAP1 and HeLa cells, consistent with the presence of
m4C at this position. This experiment also confirmed the
presence of m5C841 in human 12S mt-rRNA, known to be
methylated by NSUN4 (18) (Figure 4A and Supplementary
Figure S4E). Next, we used targeted BS RNA-Seq on
RNA samples isolated from METTL15 KO HAP1 cells
and compared the methylation of 12S mt-rRNA with
WT HAP1 cells. In WT cells we measured approximately
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Figure 3. METTL15 is a m4C methyltransferase. Structural Analysis of METTL15. (A) Homology modelling of Homo sapiens METTL15 using E. coli
RsmH as a template (PDB: 3TKA). The modelled Homo sapiens structure is superimposed onto the bacterial structure. Grey, E. coli RsmH; green,
METTL15 cytidine-binding domain; orange,METTL15methyltransferase (MTase) domain; red, S-adenosylmethionine; blue, cytidine (B,C) Catalytically
important residues responsible for AdoMet-binding. Colour coding is as per (A). Homology modelling was performed using Swiss-Model homology
modelling server and visualised using PyMol. (D, E) Comparative quantification of various modified nucleosides in mitochondrially-enriched RNA from
WT and METTL15 KO HAP1 cells. Nucleosides were quantified by LC-MS, and are expressed as a percentage of the canonical RNA bases. In (D), the
levels of several modified nucleoside are compared between the cell lines, while in (E) the m4C is displayed alone.
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Figure 4. METTL15methylates position C839 of mitochondrial 12S rRNA. (A,B) Heatmap of targeted BSRNA-Seq reads for the region of the12S rRNA
encompassing position C839 and C841 for wild type HAP1 cells (WT) (A) and METTL15 KO HAP1 cells (B), showing cytosines of individual reads (on
y-axis). Methylated cytosines are shown in grey, while unmodified cytosines are shown in blue (x-axis). (C) Summary of the targeted BS RNA-Seq results
for the C839 and C841 sites in WT and METTL15 KO HAP1 cells. (D) View of the human mtSSU from the interface between mitoribosomal subunits.
structure of the mtSSU. Putative localisation of tRNAs (green, yellow, red) are presented from structural alignment of a bacterial ribosome loaded with
these RNAs (PDB ID: 5JTE). 12S mt-rRNA is presented as an orange ribbon and MRPSs as grey cartoons. 12S mt-rRNA modifications are localised in
the three-dimensional, indicating: the position of the known modifications, m5C841, m62A936 and m62A937, for which the enzymes responsible, NSUN4
and TFB1M, respectively, were previously characterised (dark grey), the m4C839 modification, for which METTL15 was associated in the present study
(teal), and m5U429, for which the enzyme remains to be identified (light grey). Adapted from Rebelo-Guiomar et al. (45).
14% of m4C839 methylation, whereas in cells lacking a
functional METTL15 protein, the m4C839 methylation
was not detected (Figure 4B, C). In the same analysis, we
detected m5C841 modification in ∼50% of BS RNA-Seq
reads in WT cells, and the signal was reduced to ∼40%
in METTL15 KO HAP1 cells (Figure 4B, C). Analogous
reduction of the m5C841 signal upon inactivation of
METTL15, and a consequent lowering of m4C839, was
observed in the siRNA experiments (Supplementary Figure
S4E). This latter observation suggests an interdependence
of the m4C839 and m5C841 modifications. The detected
m4C839 methylation level of ∼14% in WT HAP1 appears
remarkably low compared to other rRNA methylated sites
that are usually almost completely modified (11,18,43).
This presents an apparent incongruous contrast between
the low level m4C839 and the strong effect of its absence
on mitochondrial translation. However, this potential
disparity is likely to be attributed to the low efficiency of
m4C conversion in BS RNA-Seq. Consequently, the actual
C839 methylation levels are likely to be much higher in WT
cells, explaining the observed effect in the METTL15 KO
cells. Our results are also consistent with the previously
published data reporting a degree of m4C/m5C modifica-
tion in mouse 12S mt-rRNA (18). Nevertheless, bisulfite
Nucleic Acids Research, 2019, Vol. 47, No. 19 10275
conversion clearly shows the absence of N4-methylation
of position C839 of human 12S mt-rRNA in cells lacking
a functional METTL15 (Figure 4C) and reduced m4C
levels in cells treated with siRNA against METTL15
(Supplementary Figure S4E), consistent with this enzyme
being responsible for introducing m4C839 (Figure 4D).
Catalytic activity of METTL15 is necessary for mitochon-
drial translation
In order to investigate whether it is the presence of the
METTL15 protein, its catalytic activity, or both that
are crucial for mitochondrial function we complemented
METTL15 KO cells with cDNA encoding wild type or
predicted catalytically inactive mutants of METTL15. Two
METTL15 mutants were designed: a single mutant carry-
ing E297A and a double mutant harbouring the D118A
and R119A amino acid substitutions. The E297 and D118
residues interact directly with AdoMet, whereas R119 has
an indirect interaction viawell-orderedwatermolecules (39)
(Figure 5A). Following lentiviral transduction and selec-
tion, we have confirmed expression of the METTL15 pro-
tein and variants thereof. Next, we assessed of steady state
levels of OXPHOS complexes by western blotting (Figure
5B-C) and the C839 methylation levels by BS RNA-Seq
(Figure 5D). Complementation ofMETTL15KO cells with
WT METTL15 protein resulted in a clear rescue of both
methylation and OXPHOS complex steady state levels. On
the other hand, complementationwith amutantMETTL15
protein, resulted in only very low (E297A) or no methy-
lation (D118A + R119A) of 12S mt-rRNA position C839
and no detectable correction of OXPHOS complex steady
state levels compared to METTL15 KO cells. These experi-
ments additionally confirmed our previous observation that
incorporation of m4C839 influences modification at C841
(Figure 4B-C, Supplementary Figure S4E), showing that
the loss of the C839 modification leads to reduction of the
C841 modification (Figure 5D). Taken together these data
indicate that the methylation of 12S mt-rRNA at C839 by
a catalytically active METTL15 is necessary for mitochon-
drial translation.
METTL15 is required for biogenesis of the mitochondrial ri-
bosome
We performed a sucrose gradient sedimentation of WT
HEK293T cell lysates followed by detection and relative
quantification of different components of the mt-SSU and
mt-LSU by mass spectrometry to examine the interaction
of METTL15 with the mitoribosome. Although the ma-
jority of detected METTL15 sedimented in early fractions
(fractions 1–4), we did detect partial co-sedimentaton of en-
dogenousMETTL15 with mt-SSU (Figure 6A). To corrob-
orate this analysis, we investigated whether METTL15 co-
purifies with the mitoribosome. METTL15-FLAG protein
was immunopurified from mitochondrial lysates and pro-
tein components of both the small and large mitochondrial
ribosomal subunit were immunodetected. However, we did
not observe any substantial enrichment of mt-SSU or mt-
LSU components (Figure 6B). Taken together, these results
indicate a weak interaction betweenMETTL15 and the mi-
toribosome.
We next asked whether the lack of METTL15 affects the
integrity of the mitochondrial ribosome. To unravel any po-
tential quantitative changes in the steady-state levels of the
assembled mt-SSU and mt-LSU, we combined sucrose gra-
dient sedimentation protein profiling with relative quan-
tification by stable isotope labelling with amino acids in
cell culture (SILAC). WT or METTL15 KO HAP1 cells
were grown in media containing normal amino acids or
amino acids labelled with stable heavy isotopes and sub-
jected to sucrose gradient sedimentation upon mitochon-
drial enrichment. Mitoribosomal protein components from
each fraction were identified by mass spectrometry analysis
and quantified in a relative fashion using the observed inten-
sity of a representative peptide (Supplementary Dataset).
The protein profiling data showed that the abundance of
mitoribosomal proteins was generally reduced by ∼40% in
cells lacking METTL15 as compared to WT cells, while cy-
toplasmic ribosomal proteins are detected at similar levels
in both cell lines (Figure 6C–F). These results were vali-
dated by western blot analysis of total cell lysates of cells
grown in SILAC labelling medium for uS17m and uL3m
(Figure 6G and H). This confirmed a decrease in steady-
state levels of both mt-SSU and mt-LSU in METTL15 KO
cells. Further analysis also revealed a non-statistically sig-
nificant decrease in mitochondrial transcript steady-levels,
but not in mtDNA copy number in this medium (Supple-
mentary Figure S2D–E). Northern blot analysis of mature
mt-rRNA showed a non-statistically significant decrease in
the 12S/16S ratio in METTL15 KO cells (Supplementary
Figure S2F and G). To illustrate the MRP reduction in
more detail, we compared the protein amounts of the mt-
SSU components in the sucrose gradient fractions contain-
ing mt-SSU (fractions 8 and 9) (Figure 6I). The four pro-
teins that were most reduced in METTL15 KO HAP1, as
compared to the WT control, were identified as mS38 (AU-
RKAIP1), uS12m, uS15m and uS17m (Figure 6I and J).
When the distances of all MRPSs to the C839 residue are
calculated, it is notable that the MRPSs most severely af-
fected by METTL15 knock-out are those localized in the
closest proximity to the METTL15 target site (Supplemen-
tary Figure S8). In the case of mS38, its closest contact with
residue C839 is established between the side chain of L131
and the 2′-hydroxyl of the ribose (8.1 A˚, between atoms C1
and O2′). The second closest MRP is uS12m, which con-
tacts the phosphate group of C839 via K72 (∼13 A˚ between
atoms N and OP1 or OP2). The reduction of the steady-
state levels of these proteins in the mt-SSU fractions, sug-
gests that they cannot incorporate effectively in the assem-
bling mitoribosome. Taken together, our data indicate that
the lack of m4C839 impairs the assembly of the mt-SSU in
human mitochondria and that METTL15 is necessary for
mitoribosome biogenesis.
DISCUSSION
Mitochondrial epitranscriptomics is emerging as an im-
portant aspect of studies on the regulation of mitochon-
drial gene expression, with mt-RNA modifications being
important for efficient and accurate protein synthesis in
mitochondria in health and disease (44–47). Ten post-
transcriptional modifications have been detected in mam-
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Figure 5. cDNA complementation of METTL15 KO cells.(A) Catalytically important residues, D118, R119 and E297, predicted to bind AdoMet (red),
that were subjected to site-directed mutagenesis are indicated on the homology model as per Figure 1. The dotted line represents the predicted interactions
with AdoMet based on Wei et al. (2012). (B) Western blot analysis of METTL15, NDUFB8 (complex I), SDHB (complex II), UQCRC2 (complex II),
COXII (complex IV), ATP5A (complex V) and Beta actin in wild type HAP1 cells, METTL15 KO cells, METTL15 KO cells transfected with cDNA
encoding E297A or D118A + R119A mutants or with WT METTL15 cDNA. CBS stands for Coomassie blue staining. (C) Quantification of NDUFB8
analysed by western blot (n = 3, data were statistically analysed by two-tailed Student’s t-test. Error bars represent standard deviation of the mean). (D)
Pie charts of BS RNA-Seq results showing methylation percentage of 12S mt-rRNA position C839 and C841 in wild type HAP1 cells, METTL15 KO cells,
and METTL15 KO cells complemented with E297A, D118A + R119A mutants or with WTMETTL15 cDNA.
malian mitochondrial ribosomal RNAs. Most of these
modifications and/or modifying enzymes play a role in
mitoribosome biogenesis (9,14,17). The three 2′-O-ribose
methylations of the large 16S mt-rRNA, Gm1145, Um1369
andGm1370 are catalyzed byMRM1,MRM2andMRM3,
respectively (8–10). Depletion of MRM2 and MRM3 re-
sults in aberrant assembly of the large subunit and dimin-
ishedmitochondrial protein synthesis. Furthermore, themi-
tochondrial pseudouridine synthase RPUSD4, suggested
to introduce Psi1397 in 16S mt-rRNA, is essential for the
stability of the largemitoribosomal subunit (13,14).Modifi-
cation of the two adjacent dimethylated adenosine residues
(m62A936 and m62A937) by TFB1M in human 12S mt-
rRNA has been proposed to act as a checkpoint in the
regulation of mitoribosome biogenesis, similar to the bac-
terial homolog KsgA (48), and the loss of the dimethyla-
tion impairs the assembly of mt-SSU and mitochondrial
translation (17). Finally, inactivation of NSUN4, which
methylates C841 (m5C841) of the small 12S mt-rRNA and
works in a complex with MTERF4, also affects mitoribo-
some assembly (18). The present study identifies a novel
mt-rRNA modifier: the previously uncharacterized RNA
methyltransferase METTL15, which introduces m4C839 in
the small 12S mt-rRNA.
In E. coli, C1402 located in h44 of the small subunit
16S rRNA, corresponds to C839 in human 12S mt-rRNA.
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Figure 6. Effect of METTL15 inactivation on the mitochondrial ribosome. (A) An average (n = 4) proteomic profile of mt-SSU, mt-LSU and METTL15
upon sucrose gradient sedimentation. (B) Immunopurification of components of the mitochondrial ribosome using a flag-tagged version of METTL15.
HEK293T cells expressing a flag-tagged METTL15 construct were lysed and immunoprecipitation was performed using anti-Flag antibodies. The lysate
(Input) and eluates were analysed by western blot with antibodies as indicated. (C–F)A representative quantitative sucrose gradient sedimentation analysed
by mass spectrometry. Wild type and METTL15 KO HAP1 cells were grown in heavy or light labelled medium and the different fractions after sucrose
gradient sedimentation were analysed by mass spectrometry. Graphical representation of total mt-SSU proteins (C) and cytoplasmic SSU proteins (D)
or mt-LSU proteins (E) and cytoplasmic LSU proteins (F) detected in each fraction for wild type (grey) or METTL15 KO HAP1 (blue) cells. See also
Supplementary Dataset. (G) Western blot analysis of three independent wild type and METTL15 KO HAP1 samples for uS17m, uL3m and Beta-actin.
CBS stands for Coomassie blue staining. Asterisk represents non-specific bands. (H) Quantification of band intensities shown in G (n = 3, data were
statistically analysed by two-tailed Student’s t-test. Error bars represent standard deviation of the mean). (I) Protein steady-state levels of the mt-SSU
components in METTL15 KO HAP1 cells, relative to wild type control cells, in the mt-SSU fractions. The most affected proteins are coloured. The
results were obtained from duplicate experiments with reciprocal SILAC (Control:heavy/METTL15 KO:light or Control:light/METTL15 KO:heavy) (J)
Representative example of relative intensity profiles of the mt-SSU proteins detected in METTL15 KO HAP1 that were in the bottom 20% of steady state
level values, as compared to the WT control.
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The SSU C1402 has a unique methyl modification, N4,
2′-O-dimethylcytidine (m4Cm) (49), which is conserved in
other bacteria (50–52). This N4-methylated cytidine, gener-
ated by the METTL15 ortholog RsmH, interacts directly
with the P-site codon of the mRNA (53). In the absence
of RsmH, non-AUG initiation is increased and stop codon
read-through is decreased. The 2′-O-methyl modification at
C839 is not conserved in mammalian mitochondrial RNA,
however, the N4-methyl at this position is strongly con-
served. In the mitochondrial ribosome, the m4C839 modifi-
cation is also predicted to be located near the P-site codon
of the mRNA, suggesting a role in decoding (Supplemen-
tary Figure S8) (1,4). In humans, mitochondrial translation
occasionally initiates with AUA (MT-ND1,MT-ND3,MT-
ND5) or AUU (MT-ND2) instead of the universal start
codon AUG. In accordance with its bacterial function, we
suggest that the m4C839 methylation plays a role in fine-
tuning the shape and function of the P-site and as such in-
creasing decoding fidelity, in particular the correct recog-
nition of the initiation codon, however, more research is
needed to support this hypothesis.
It has been shown that bacterial RsmH recognizes the
small ribosomal subunit as a substrate, but not the naked
rRNA or the tightly-coupled monosome (53). This is con-
sistent with RsmH acting on later stages of biogenesis of
the bacterial small ribosomal subunit. The co-migration of
theMETTL15 pool with mt-SSU (Figure 6A) also suggests
that the mitochondrial small ribosomal subunit is a sub-
strate for this enzyme. It has been suggested previously that
m4C839 and its neighbouring methylated cytidine at posi-
tion 841 are involved in the stabilization of 12S rRNA fold-
ing and thereby facilitating mitoribosomal assembly (18).
Our data demonstrate that in the absence of METTL15
the biogenesis of the mt-SSU is generally impaired, with a
subset of mt-SSU components (mS38, uS15m, uS17m and
uS12m) being affected to a greater degree. However, the
partial inhibition of mitochondrial protein synthesis (Fig-
ure 2B and C) suggests that fully assembled mt-SSU is also
formed in theMETTL15KO cells. The structural data show
that mS38 is located in the proximity of 12Smt-rRNAC839
(Figure 7A, B, Supplementary Figure S6) (1,4). The aber-
rant incorporation of mS38 could be caused by its inabil-
ity to interact with improperly folded 12S mt-rRNA in the
absence of m4C839. The uS15m protein is also within the
subset of mt-SSU proteins most affected by the absence
of METTL15 (Figure 6I and J). The structure of human
mt-SSU shows that uS15 is the only mt-SSU protein that
interacts with mS38 (1,4), therefore, the assembly of these
two proteins could be interdependent. This is consistent
with a recent study by Bogenhagen et al. (7) on the ki-
netics of mitoribosome assembly that indicates uS15m as
part of a late stage mt-SSU assembly cluster (also includ-
ing mS25 and mS26) that associates with mS38. Our anal-
ysis also shows that assembly of uS12m into the mt-SSU
is severely altered in the absence of METTL15 (Figure 6I,
J and Figure 7A and C). Since this protein is also located
near position C839 (Supplementary Figure S8), this rein-
forces the notion that methylation of C839 introduces a
structural change necessary for uS12m to bind. Further-
more, uS17m, a mt-SSU protein that interacts with both
uS15 and uS12m, also shows a more substantial downregu-
lation in the METTL15 KO cells. The kinetic model by Bo-
genhagen et al. suggests that uS12m and uS17m are early
binding proteins that incorporate into the mt-SSU as in-
dividual proteins. Neither uS12m or uS17m contacts other
early-binding proteins, so their addition appears to depend
on their substantial interactionswith 12Smt-rRNA.Conse-
quently, a potential structural change of the 12S mt-rRNA
in the absence of METTL15 could prevent stable protein-
RNA interactions of uS12m and uS17m during the progress
of mt-SSU biogenesis. Moreover, our experiments showed
interdependence of m4C839 and the neighbouring m5C841,
with the loss of the C839 modification resulting in reduc-
tion of the C841 modification (Figure 4B, C, Supplemen-
tary Figure S4E and Figure 5D). The latter observation
could also be related to a potential structural change in h44
of the 12S mt-rRNA, preventing efficient modification of
C841 by the NSUN4-MTERF4 complex (18). Taken to-
gether, our results provide useful novel information for the
study of the mitoribosome assembly process pointing out
that METTL15 is required for mt-SSU assembly by regu-
lating local protein-RNA interactions in the vicinity of the
C839 site, possibly at the late stages of mitoribosome bio-
genesis (Figure 7D). Given the decrease in the steady-state
levels of mt-LSU in METTL15 KO cells, it would be in-
teresting to explore if METTL15 has other RNA or even
protein substrates in addition to 12S mt-rRNA.
A recent study suggested that METTL15 is a part of
BioID interactome of a mitochondrial pseudouridine syn-
thase TRUB2. TRUB2 has been shown to interact with sev-
eral proteins of the mt-LSU as well as with other mitochon-
drial proteins involved in mt-LSU assembly (13,54). This
may indicate that METTL15 could potentially play a role
in the mt-LSU biogenesis together with TRUB2. The ob-
served general downregulation of the steady-state levels of
mt-LSU in METTL15 KO, in addition to downregulation
of mt-SSU, might indeed suggest a role of METTL15 in the
production of mitochondrial large subunit. If METTL15
were to be involved in the mt-LSU assembly together with
TRUB2, as the interaction detected by BioID suggests, this
would have to be a secondary role for METTL15 in mito-
chondria that needs further investigation, including a de-
tailed characterization of protein-protein interaction using
orthogonal methodology.
Manymethyltransferases involved in rRNAmodification
and ribosome assembly have uncoupled (dual) functions
i.e. the catalytic activity of an enzyme on rRNA is inde-
pendent from its role in ribosome biogenesis (e.g. its phys-
ical presence in maturing subunits, as a building block of
pre-ribosomes). For example, the yeast MRM1 ortholog,
Pet56p, has an essential role in the maturation of mt-LSU
that is independent from itsmethyltransferase activity. Also,
mammalian NSUN4 is, on the one hand, needed for 12S
rRNA methylation and on the other hand, it interacts with
MTERF4 to facilitatemonosome assembly (18). Our exper-
iments indicate that not only the presence ofMETTL15, but
also its methyltransferase activity is necessary for mitori-
bosome function (Figure 5A–D). It remains to be investi-
gated whether the function of other mt-rRNAmethyltrans-
fereses (e.g.MRM1,MRM2,MRM3, TRMT61B, TFB1M
(9–11,28,55)) in mitoribosome assembly is coupled to their
catalytic activity.
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Figure 7. Possible role of methylation of position C839 of mitochondrial 12S rRNA. (A) Structure of mt-SSU (PDB: 5AJ4) (4) indicating the proteins that
are downregulated in METTL15 KO as compared to WT samples. uS15m in dark blue, uS17m in light blue, mS38 in red and uS12m in orange. (B) Detail
of (A) showing the localisation of mS38 (red) and mt-rRNA positions C839 and C841. (C) Detail of (A) showing the localisation of uS12m (orange) and
mt-rRNA positions C839 and C841. (D) Model for the role of METTL15 in mt-SSU assembly. (i) Partially assembled mt-SSU. (ii) METTL15 methylates
12S mt-rRNA at C839. Teal sphere denotes the methyl group. (iii) Methylation of C839 introduces a structural change on 12S mt-tRNA and enables the
incorporation of late stage ribosomal components into mt-SSU.
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In summary, we have identified the mitochondrial sub-
strate for the previously uncharacterizedN4-methylcytidine
RNA methyltransferase METTL15. We demonstrate that
this protein is the main human m4C methyltransferase and
modifies C839 in 12S mt-rRNA. The lack of functional
METTL15 protein affects mitoribosomal biogenesis, mito-
chondrial translation and, consistent with this, mitochon-
drial OXPHOS performance. Moreover, the function of
METTL15 in mitochondrial translation is dependent on its
methyltransferase catalytic activity suggesting that theC839
modification itself plays a role in mitoribosome biogenesis
and/or stability. The exact molecular role of the m4C839
modification in mRNA decoding still remains to be deter-
mined. However, since the lack ofMETTL15 affects assem-
bly of the small subunit of the mitochondrial ribosome and
because of its position in the ribosome, we speculate thatN4
methylation of position 839, possibly in cooperation with
m5C841, is involved in stabilization of 12S rRNA folding
and thereby facilitating late stages of mitoribosomal assem-
bly.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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